Press releases

31 March, 2014

Regulatory

NeuroVive Pharmaceutical AB—amendment number of shares and votes

Pursuant to chapter 4, § 9 of the Swedish Financial Instruments Trading Act (1991:980), the company is hereby reporting that as a result of new share issues conducted by NeuroVive Pharmaceutical AB (p ...

13 March, 2014

Regulatory

NeuroVive Pharmaceutical AB—amendment number of shares and votes

As a result of new share issues conducted by NeuroVive Pharmaceutical AB (publ) ("NeuroVive"), as resolved by an Extraordinary General Meeting (EGM) on 13 December 2013, and decided by the Board of Di ...